Ahmed M. S. Hegazy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ahmed M. S. Hegazy has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Ekramy Mahmoud Elmorsy
Center for Health Research, Northern Border University, Arar, Saudi Arabia
3 shared publications - Saad El Shafey
Department of Anatomy, College of Medicine, Northern Border University, Arar, Kingdom of Saudi Arabia
3 shared publications - Amgad N. Elsawy
Department of Anatomy, Faculty of Medicine, Northern Border University, Arar, KSA
2 shared publications - Ayat Badr Al-Ghafari
King Abdulaziz University
2 shared publications - Durre Sameen Khan
Clinic of Radiology, Private Radiology Clinic, Rawalpindi, Pakistan
2 shared publications - Huda Abdulaziz Al Doghaither
Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia
2 shared publications
Latest Publications
- 15 September 2026
- Published by Elsevier in Tissue and Cell
- Vol. 104 (Pt 2) , 103966
Chrysin-Loaded Casein Nanoparticles Protect Against Chlorfenapyr-Induced Renal Injury Through Modulation of Nrf2/HO-1, NF-κB, and Mitochondrial Bioenergetics
- 15 September 2026
- Published by Elsevier in Tissue and Cell
- Vol. 104 (Pt 2) , 103966
Chrysin-Loaded Casein Nanoparticles Protect Against Chlorfenapyr-Induced Renal Injury Through Modulation of Nrf2/HO-1, NF-κB, and Mitochondrial Bioenergetics
- 1 July 2026
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 17 (7) , 763-767
Maternal exposure to environmental noise: current evidence on pregnancy outcomes
Noise pollution has become an important public health issue, particularly in densely populated urban areas. Emerging evidence suggests that exposure to environmental noise during pregnancy may be associated with adverse maternal and fetal outcomes, including low birth weight, preterm birth, gestational hypertension, and impaired fetal development. This review summarizes current evidence on the effects of environmental noise exposure during pregnancy and discusses major sources such as traffic, industrial activities, and construction work. Potential mechanisms include stress-related hormonal changes, sleep disturbance, and cardiovascular effects that may adversely affect the intrauterine environment. Although growing evidence supports these associations, important gaps remain regarding dose-response relationships, long-term effects on offspring, and the influence of socioeconomic and geographic factors. Greater awareness and further research may help improve reproductive health outcomes and support the development of effective public health policies.
- 1 July 2026
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 17 (7) , 763-767
Maternal exposure to environmental noise: current evidence on pregnancy outcomes
Noise pollution has become an important public health issue, particularly in densely populated urban areas. Emerging evidence suggests that exposure to environmental noise during pregnancy may be associated with adverse maternal and fetal outcomes, including low birth weight, preterm birth, gestational hypertension, and impaired fetal development. This review summarizes current evidence on the effects of environmental noise exposure during pregnancy and discusses major sources such as traffic, industrial activities, and construction work. Potential mechanisms include stress-related hormonal changes, sleep disturbance, and cardiovascular effects that may adversely affect the intrauterine environment. Although growing evidence supports these associations, important gaps remain regarding dose-response relationships, long-term effects on offspring, and the influence of socioeconomic and geographic factors. Greater awareness and further research may help improve reproductive health outcomes and support the development of effective public health policies.
- 6 May 2026
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 53 (5) , e70129
Targeting Nrf2/ HO ‐1, NF ‐ κ B , and Apoptotic Pathways: Mechanistic Evaluation of Phlorizin Nanoparticles in Diabetic Renal Injury
Diabetes mellitus (DM) is a chronic metabolic disorder associated with hyperglycemia, dyslipidemia, oxidative stress, inflammation, apoptosis, and renal dysfunction. Although phlorizin (PHL) possesses well‐documented antidiabetic properties, its clinical applicability is limited by poor bioavailability and rapid metabolism, which may restrict its therapeutic efficacy. This study evaluated the therapeutic potential of phlorizin (PHL) and its chitosan nanoparticle formulation (PHL‐CSNPs) in streptozotocin (STZ)‐induced type 1 diabetic rats. Ninety adult male albino rats were randomly divided into six groups ( n = 15 each): non‐diabetic control, non‐diabetic treated with crude PHL, non‐diabetic treated with PHL‐CSNPs, diabetic untreated (STZ‐induced T1DM), diabetic treated with crude PHL, and diabetic treated with PHL‐CSNPs. STZ‐induced T1DM caused significant reductions in serum insulin, body weight gain, renal antioxidant defences, and mitochondrial function, accompanied by marked elevations in fasting blood glucose, dyslipidemia, oxidative stress markers, pro‐inflammatory cytokines, apoptotic markers, and renal fibrotic mediators, as well as pronounced histopathological and ultrastructural kidney damage. In diabetic rats, treatment with PHL‐CSNPs significantly improved insulin levels, glucose homeostasis, and body weight, restored lipid profiles and antioxidant enzyme activities, enhanced mitochondrial respiratory complex activities and ATP production, suppressed NF‐ κ B–mediated inflammation, upregulated Nrf2/HO‐1 signalling, decreased Bax and caspase‐3 levels, increased Bcl‐2 levels, and reduced TGF‐ β 1–mediated fibrosis. Crude PHL provided moderate protective effects but was consistently less effective than the nanoparticle formulation. Importantly, the chitosan nanoparticle formulation markedly enhanced the therapeutic efficacy of PHL, likely by improving its stability, bioavailability, and renal tissue delivery, thereby producing stronger antioxidant, anti‐inflammatory, and anti‐apoptotic effects than crude PHL. Non‐diabetic rats treated with either PHL or PHL‐CSNPs maintained normal metabolic and renal parameters, confirming the safety of the treatments. Histopathological and ultrastructural analyses further confirmed the preservation of renal architecture in PHL‐CSNP–treated diabetic rats. Collectively, this study demonstrates that nanoencapsulation significantly potentiates the biological activity of PHL, providing a clear therapeutic advantage over the crude compound. Overall, these findings demonstrate that PHL‐CSNPs provide superior nephroprotective, antioxidant, anti‐inflammatory, and metabolic benefits, highlighting their potential as a promising therapeutic strategy for managing type 1 diabetes‐induced metabolic and renal complications.
- 6 May 2026
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 53 (5) , e70129
Targeting Nrf2/ HO ‐1, NF ‐ κ B , and Apoptotic Pathways: Mechanistic Evaluation of Phlorizin Nanoparticles in Diabetic Renal Injury
Diabetes mellitus (DM) is a chronic metabolic disorder associated with hyperglycemia, dyslipidemia, oxidative stress, inflammation, apoptosis, and renal dysfunction. Although phlorizin (PHL) possesses well‐documented antidiabetic properties, its clinical applicability is limited by poor bioavailability and rapid metabolism, which may restrict its therapeutic efficacy. This study evaluated the therapeutic potential of phlorizin (PHL) and its chitosan nanoparticle formulation (PHL‐CSNPs) in streptozotocin (STZ)‐induced type 1 diabetic rats. Ninety adult male albino rats were randomly divided into six groups ( n = 15 each): non‐diabetic control, non‐diabetic treated with crude PHL, non‐diabetic treated with PHL‐CSNPs, diabetic untreated (STZ‐induced T1DM), diabetic treated with crude PHL, and diabetic treated with PHL‐CSNPs. STZ‐induced T1DM caused significant reductions in serum insulin, body weight gain, renal antioxidant defences, and mitochondrial function, accompanied by marked elevations in fasting blood glucose, dyslipidemia, oxidative stress markers, pro‐inflammatory cytokines, apoptotic markers, and renal fibrotic mediators, as well as pronounced histopathological and ultrastructural kidney damage. In diabetic rats, treatment with PHL‐CSNPs significantly improved insulin levels, glucose homeostasis, and body weight, restored lipid profiles and antioxidant enzyme activities, enhanced mitochondrial respiratory complex activities and ATP production, suppressed NF‐ κ B–mediated inflammation, upregulated Nrf2/HO‐1 signalling, decreased Bax and caspase‐3 levels, increased Bcl‐2 levels, and reduced TGF‐ β 1–mediated fibrosis. Crude PHL provided moderate protective effects but was consistently less effective than the nanoparticle formulation. Importantly, the chitosan nanoparticle formulation markedly enhanced the therapeutic efficacy of PHL, likely by improving its stability, bioavailability, and renal tissue delivery, thereby producing stronger antioxidant, anti‐inflammatory, and anti‐apoptotic effects than crude PHL. Non‐diabetic rats treated with either PHL or PHL‐CSNPs maintained normal metabolic and renal parameters, confirming the safety of the treatments. Histopathological and ultrastructural analyses further confirmed the preservation of renal architecture in PHL‐CSNP–treated diabetic rats. Collectively, this study demonstrates that nanoencapsulation significantly potentiates the biological activity of PHL, providing a clear therapeutic advantage over the crude compound. Overall, these findings demonstrate that PHL‐CSNPs provide superior nephroprotective, antioxidant, anti‐inflammatory, and metabolic benefits, highlighting their potential as a promising therapeutic strategy for managing type 1 diabetes‐induced metabolic and renal complications.
- 20 March 2026
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 17 (suppl2) , 206-210
Impact of mobile phone use during pregnancy on fetal development and birth defects: a review
Mobile phones are integral to modern life, but their potential health impacts, particularly on vulnerable groups such as pregnant women, have raised scientific concerns. The electromagnetic radiation (EMR) emitted by mobile phones is linked to biological effects, including oxidative stress, DNA damage, and cellular disruption, prompting intriguing questions about its influence on fetal development. Research highlights both direct and indirect effects of mobile phone use during pregnancy. Direct effects involve EMR’s potential to interfere with cellular processes that may impact fetal growth. Indirect effects, meanwhile, stem from behavioral changes associated with phone usage, such as increased sedentary habits and disrupted sleep patterns, which can also affect maternal and fetal health. The advent of advanced technologies like 5G adds complexity to these concerns. While 5G networks provide faster connectivity, they operate at higher frequencies, raising new questions about potential health risks. However, disentangling direct effects of EMR from confounding factors like lifestyle and environmental variables remains challenging, requiring further investigation. This review consolidates current evidence on mobile phone usage during pregnancy, focusing on its direct biological effects, behavioral consequences, and emerging risks linked to new technologies. Although conclusive findings are still limited, existing research emphasizes the need for caution. Pregnant women and healthcare providers should stay informed about ongoing studies to make prudent decisions about mobile phone use. Continued long-term research is essential to clarify the interaction between EMR exposure and maternal-fetal health, ensuring a better understanding of its potential risks.
- 20 March 2026
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 17 (suppl2) , 206-210
Impact of mobile phone use during pregnancy on fetal development and birth defects: a review
Mobile phones are integral to modern life, but their potential health impacts, particularly on vulnerable groups such as pregnant women, have raised scientific concerns. The electromagnetic radiation (EMR) emitted by mobile phones is linked to biological effects, including oxidative stress, DNA damage, and cellular disruption, prompting intriguing questions about its influence on fetal development. Research highlights both direct and indirect effects of mobile phone use during pregnancy. Direct effects involve EMR’s potential to interfere with cellular processes that may impact fetal growth. Indirect effects, meanwhile, stem from behavioral changes associated with phone usage, such as increased sedentary habits and disrupted sleep patterns, which can also affect maternal and fetal health. The advent of advanced technologies like 5G adds complexity to these concerns. While 5G networks provide faster connectivity, they operate at higher frequencies, raising new questions about potential health risks. However, disentangling direct effects of EMR from confounding factors like lifestyle and environmental variables remains challenging, requiring further investigation. This review consolidates current evidence on mobile phone usage during pregnancy, focusing on its direct biological effects, behavioral consequences, and emerging risks linked to new technologies. Although conclusive findings are still limited, existing research emphasizes the need for caution. Pregnant women and healthcare providers should stay informed about ongoing studies to make prudent decisions about mobile phone use. Continued long-term research is essential to clarify the interaction between EMR exposure and maternal-fetal health, ensuring a better understanding of its potential risks.
- 1 May 2025
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 16 (5) , 364-368
The extent of awareness and knowledge of people in the Northern Border Region of Saudi Arabia about the effect of diabetes mellitus on the retina
Aim Diabetic ocular complications, especially diabetic retinopathy (DR), are a major cause that leads to irreversible blindness. Awareness of diabetes and its ocular complications may help in preventing vision loss. This study evaluates the awareness of people (diabetics and non-diabetics) about the complications of diabetes in the eye, especially the retina. Methods This study is a questionnaire-based cross-sectional study. Data was collected through an online self-administered questionnaire. The target people from 16 years to 75years in both males and females The duration of the study from May 2024 to September 2024 The comparisons between the awareness about diabetic retinopathy and the association of awareness about diabetic retinopathy and educational level were analyzed using SPSS 24.0 version software. Results The study included 153 individuals. The age range of participants was 16–75, and the most dominant age group was those with an age range of 46–55 (35.7%). The ratio of male to female was 58.8:41.2, regarding education, the most dominant group was those who had a university education, 80 (52.3%), then higher education level 46 (30.1). Most of the participants, 127 (83%) non-diabetic and 26 (17%) diagnosed with Diabetes mellitus. Of most of the participants, 141(80 males and 61 females), 92.2% of participants reported that diabetes affects the retina, and 87(45 males and 42 females) 56.9% agreed with the relation between diabetic retinopathy and blindness. 121(67 males and 54 females) 79.1% of participants reported that the control of blood glucose level can prevent diabetic retinopathy There was high awareness among the participants, diabetic and non-diabetic, regarding diabetic retinopathy (DR), but annual check-ups were done in less than half of the patients. Improvement is required for scheduling annual eye examinations for the early detection of diabetic retinopathy (DR). Conclusion The results of this study showed a high level of self-report awareness regarding the association between DM and retinopathy. These results are in harmony with other local and international studies. All these studies found that the awareness regarding the association between DM and retinopathy is high among the people of higher education. This is due to the spread of social media, which has led to increased awareness among many people. The strength of this study included patients of all ages from 16 to 75, and Most of the participants have a university education or higher.
- 1 May 2025
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 16 (5) , 364-368
The extent of awareness and knowledge of people in the Northern Border Region of Saudi Arabia about the effect of diabetes mellitus on the retina
Aim Diabetic ocular complications, especially diabetic retinopathy (DR), are a major cause that leads to irreversible blindness. Awareness of diabetes and its ocular complications may help in preventing vision loss. This study evaluates the awareness of people (diabetics and non-diabetics) about the complications of diabetes in the eye, especially the retina. Methods This study is a questionnaire-based cross-sectional study. Data was collected through an online self-administered questionnaire. The target people from 16 years to 75years in both males and females The duration of the study from May 2024 to September 2024 The comparisons between the awareness about diabetic retinopathy and the association of awareness about diabetic retinopathy and educational level were analyzed using SPSS 24.0 version software. Results The study included 153 individuals. The age range of participants was 16–75, and the most dominant age group was those with an age range of 46–55 (35.7%). The ratio of male to female was 58.8:41.2, regarding education, the most dominant group was those who had a university education, 80 (52.3%), then higher education level 46 (30.1). Most of the participants, 127 (83%) non-diabetic and 26 (17%) diagnosed with Diabetes mellitus. Of most of the participants, 141(80 males and 61 females), 92.2% of participants reported that diabetes affects the retina, and 87(45 males and 42 females) 56.9% agreed with the relation between diabetic retinopathy and blindness. 121(67 males and 54 females) 79.1% of participants reported that the control of blood glucose level can prevent diabetic retinopathy There was high awareness among the participants, diabetic and non-diabetic, regarding diabetic retinopathy (DR), but annual check-ups were done in less than half of the patients. Improvement is required for scheduling annual eye examinations for the early detection of diabetic retinopathy (DR). Conclusion The results of this study showed a high level of self-report awareness regarding the association between DM and retinopathy. These results are in harmony with other local and international studies. All these studies found that the awareness regarding the association between DM and retinopathy is high among the people of higher education. This is due to the spread of social media, which has led to increased awareness among many people. The strength of this study included patients of all ages from 16 to 75, and Most of the participants have a university education or higher.
- 25 November 2021
- Published by Taylor & Francis in Cutaneous and Ocular Toxicology
- Vol. 41 (1) , 33-42
Curcumin and ustekinumab cotherapy alleviates induced psoriasis in rats through their antioxidant, anti-inflammatory, and antiproliferative effects
Psoriasis is a chronic multifactorial inflammatory disease that affects 3% of people worldwide. Ustekinumab is a selective anti-IL-12/23 biologic that alleviates psoriasis, and curcumin is a natura...
- 25 November 2021
- Published by Taylor & Francis in Cutaneous and Ocular Toxicology
- Vol. 41 (1) , 33-42
Curcumin and ustekinumab cotherapy alleviates induced psoriasis in rats through their antioxidant, anti-inflammatory, and antiproliferative effects
Psoriasis is a chronic multifactorial inflammatory disease that affects 3% of people worldwide. Ustekinumab is a selective anti-IL-12/23 biologic that alleviates psoriasis, and curcumin is a natura...